Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 12/20 | 0.48 |
| ▸ | CTSK | P43235 | 10/20 | 0.48 |
| ▸ | CTSB | P07858 | 3/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
| ▸ | PPARA | Q07869 | 3/20 | 0.45 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28969900 | 0.90 | CTSS (0.49) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL13102997 | 0.87 | CTSS (0.47) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL16807987 | 0.87 | CTSS (0.47) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL13970822 | 0.87 | CTSS (0.50) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL15764473 | 0.86 | ADORA1 (0.49) | CTSSCTSKCTSBCTSLADORA1 | |
| SCHEMBL17884338 | 0.86 | CTSS (0.46) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL15764469 | 0.86 | CTSS (0.56) | CTSSCTSKCTSBCTSL | |
| SCHEMBL23007573 | 0.85 | CTSS (0.44) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL17880442 | 0.84 | CTSS (0.42) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL21084961 | 0.84 | PPARA (0.61) | ADORA1KIF11PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932365-B2 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2018-04-03 | — | — | US | disclosed |
| US-20170283456-A1 | PROTEIN LABELING WITH CYANOBENZOTHIAZOLE CONJUGATES | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2017-10-05 | — | — | US | disclosed |
| US-9689868-B2 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2017-06-27 | — | — | US | disclosed |
| EP-2626703-B1 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORP (US) | 2017-05-03 | — | — | EP | disclosed |
| EP-3141905-A1 | PROTEIN LABELING WITH CYANOBENZOTHIAZOLE CONJUGATES | Promega Corporation (US) | 2017-03-15 | — | — | EP | disclosed |
| US-20170016888-A1 | PROTEIN LABELING WITH CYANOBENZOTHIAZOLE CONJUGATES | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2017-01-19 | — | — | US | disclosed |
| US-9459249-B2 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2016-10-04 | — | — | US | disclosed |
| EP-2626703-A1 | Protein labeling with cyanobenzothiazole conjugates | Promega Corporation (US) | 2013-08-14 | — | — | EP | disclosed |
| US-20090263843-A1 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263843-A1 | Protein labeling with cyanobenzothiazole conjugates | QPCTL, BCAT1, QPCT | CTSS 3778/4885CTSK 3866/4885CTSB 2667/4885 |
| US-20170283456-A1 | PROTEIN LABELING WITH CYANOBENZOTHIAZOLE CONJUGATES | QPCTL, BCAT1, QPCT | CTSS 3778/4885CTSK 3866/4885CTSB 2667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.